Loading clinical trials...
Loading clinical trials...
The aim of the current trial is to evaluate the efficacy and safety of flat-dose nivolumab (40 mg) in combination with AVD in the management of patients with newly diagnosed advanced classic Hodgkin L...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Medical Research Radiological Centre of the Ministry of Health of Russia
NCT04638790 · Hodgkin Lymphoma, Adult
NCT04378647 · Hodgkin Lymphoma, Adult
NCT04758650 · Solid Malignancy Located in the Head and Neck, Cancer, and more
NCT04636255 · Hodgkin Lymphoma, Adult, Cardiovascular Diseases, and more
NCT04292626 · Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Adult
P. Hertsen Moscow Oncology Research Institute (MORI) for administrative and economic work - the branch of the FSBI "National Medical Research Radiological Centre" (NMRRC) of the Ministry of Health of the Russian Federation
Moscow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions